| |
Company
Roster
|
|
Total
Insiders : |
48 |
|
|
|
Total
Direct Shares :
|
24,295,171 |
|
|
Total
Indirect Shares :
|
135,205,380 |
| |
%
Held by Insiders:
|
16.64% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Klassen Preston |
|
2025-06-03 |
48,055 |
2025-01-09 |
0 |
| Baltimore David |
|
2025-04-30 |
84,669 |
2025-04-30 |
62,500 |
| Collier Kathryn J |
|
2025-04-30 |
69,240 |
2018-04-14 |
0 |
| Rosen Hugh |
|
2025-04-30 |
64,271 |
2017-12-04 |
0 |
| Huang Alice Shih-Hou |
|
2025-04-30 |
62,500 |
2025-04-30 |
84,669 |
| Papadopoulos Stelios |
|
2025-04-30 |
1,040,888 |
2014-12-12 |
0 |
| Witz Pascale |
|
2025-04-30 |
67,233 |
2017-12-04 |
0 |
| Nunn Jason Raleigh |
|
2025-04-30 |
62,500 |
2025-04-30 |
0 |
| Hagan Joseph P |
|
2025-01-30 |
260,808 |
2020-12-04 |
225,674 |
| Aker Christopher Ray |
|
2025-01-14 |
49,546 |
2019-02-05 |
0 |
| Calsada Crispina |
|
2025-01-14 |
45,478 |
2024-01-12 |
0 |
| Drygin Denis |
Chief Scientific Officer |
2022-03-01 |
100,000 |
2022-02-04 |
0 |
| Nea 16 Gp, Llc |
10% Owner |
2020-12-04 |
6,451,056 |
|
0 |
| Sarissa Capital Master Fund Ii Lp |
10% Owner |
2020-04-01 |
76,356 |
|
0 |
| Chevallard Daniel R. |
Chief Financial Officer |
2019-07-01 |
77,870 |
|
0 |
| Chang Carmen |
10% Owner |
2019-05-07 |
0 |
2020-12-04 |
6,451,056 |
| Behbahani Ali |
10% Owner |
2019-05-07 |
0 |
2020-12-04 |
6,451,056 |
| Walker Paul Edward |
10% Owner |
2019-05-07 |
0 |
2020-12-04 |
6,451,056 |
| Wright Timothy Michael |
Chief R & D Officer |
2019-02-05 |
62,893 |
2017-07-25 |
0 |
| Foletta Mark G |
Director |
2017-12-04 |
81,910 |
2015-08-13 |
0 |
| Alnylam Pharmaceuticals, Inc. |
10% Owner |
2016-02-23 |
4,896,716 |
2012-10-10 |
0 |
| Rastetter William H |
|
2015-07-20 |
0 |
2025-04-30 |
101,556 |
| Isis Pharmaceuticals Inc |
10% Owner |
2015-07-17 |
5,173,172 |
2012-10-10 |
0 |
| Xanthopoulos Kleanthis G |
President and CEO, Director |
2015-04-21 |
3,705 |
2015-04-21 |
80,216 |
| Carter Bruce L A |
Director |
2015-04-13 |
0 |
2015-04-13 |
0 |
| Gibson Neil W |
Chief Scientific Officer |
2015-01-28 |
0 |
2013-02-04 |
0 |
| Parshall B Lynne |
Director |
2014-11-03 |
5,516,305 |
2012-10-10 |
7,049,500 |
| Maraganore John |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
| Greene Barry E |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
| Crooke Stanley T |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
| Puttagunta Chetan |
10% Owner |
|
0 |
2017-07-24 |
10,989,010 |
| Sakoda Jon |
10% Owner |
|
0 |
2017-07-24 |
10,989,010 |
| Mott David M |
10% Owner |
|
0 |
2019-05-07 |
2,052,454 |
| Sanofi-Aventis |
10% Owner |
|
0 |
2014-02-04 |
5,053,779 |
| Astrazeneca Ab |
10% Owner |
|
0 |
2014-11-12 |
4,250,000 |
| Simeonidis Simos |
Director |
|
0 |
2019-06-06 |
1,851,851 |
| Viswanathan Ravi |
10% Owner |
|
0 |
2017-07-24 |
10,989,010 |
| Barris Peter J |
10% Owner |
|
0 |
2019-05-07 |
2,052,454 |
| Makower Joshua |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
| Menzel Garry E |
Officer |
|
0 |
2012-10-04 |
111,842 |
| Sarissa Capital Offshore Master Fund Lp |
10% Owner |
|
0 |
2019-05-07 |
1,851,851 |
| Sandell Scott D |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
| Deeg Mark Albert |
|
|
0 |
|
0 |
| Florence Anthony A. Jr. |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
| Makhzoumi Mohamad |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
| Sonsini Peter W. |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
| Baskett Forest |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
| Szekeres David Leslie |
|
|
0 |
|
0 |
|
0.11 (1.36%) 
